Research · Dental implants
Which medicines affect dental implants, and should I stop any before surgery?
The short answer
A few do. Bone-strengthening drugs such as bisphosphonates carry a small risk of a jawbone problem called MRONJ 1, 2. Blood thinners can add some minor bleeding after surgery, which the dentist usually controls at the chair 3, 4. Some antidepressants and stomach-acid tablets have been linked to more implant failure 5, 6, 7. Never stop a prescribed medicine on your own. Your dentist and the doctor who prescribed it decide case by case.
Before implants, in the consults I translate, we make sure everything is very carefully checked. Not only gum disease, grinding, medicines and smoking, but also diabetes and stuff like that. It's a lot. To do implants, we have to ask a lot.
- Bone-strengthening drugs for osteoporosis were linked to MRONJ, where an area of jawbone fails to heal, though it is rare 1, 2.
- Implants themselves did not clearly fail more often at osteoporosis doses, and a 2026 study found the same survival with denosumab 1, 13.
- High doses of the same drugs, used for cancer, are a different and higher-risk situation 8, 9.
- Reviews on blood thinners found the extra bleeding was minor and controlled at the chair, and a French study found most of it came in the first week 3, 12.
- Some antidepressants and stomach-acid tablets were linked to more implant failure, but that does not prove the tablet is the cause 5, 6, 7.
- Whether anything changes around surgery is decided case by case, by the dentist and the doctor who prescribed the medicine.
The answer at a glance
Most medicines do not change an implant plan. A few groups do, and they matter in different ways. This table sums up what the research found for each one.
| Medicine group | Common examples | What the research found | What it usually means |
|---|---|---|---|
| Bone-strengthening drugs at osteoporosis doses | Alendronate, risedronate, zoledronic acid once a year, denosumab every six months | Implant failure not clearly higher; MRONJ after implants in 0.5% pooled across 21 cohorts 1 | Implants often possible, with care; the dentist needs the drug, dose and start date |
| The same drugs at cancer doses | Monthly zoledronic acid or denosumab for cancer that has spread to bone | High risk of complications after implant surgery 8 | Implants widely discouraged; any plan belongs in a centre set up for such cases 9 |
| Blood thinners | Warfarin, apixaban, rivaroxaban, dabigatran, aspirin, clopidogrel | More bleeding, but minor and controlled with local measures 3, 4 | Never stop on your own; dentist and doctor decide together |
| SSRI antidepressants | Sertraline, fluoxetine, citalopram, escitalopram | Failure risk about doubled in observational studies, risk ratio 2.44 5, 11 | Keep taking it; tell the dentist so healing is watched |
| Stomach-acid tablets (PPIs) | Omeprazole, esomeprazole, pantoprazole | More failure in raw data, not significant after adjusting, odds ratio 1.44 6 | Keep taking it; list it on the form |
| Anti-inflammatory painkillers used long term | Ibuprofen, naproxen, diclofenac | Long-term use linked to more failure or bone loss in a scoping review 14 | Tell the dentist how often you take them |
| Blood pressure tablets and immune-suppressing drugs | Many types | No effect on implant outcomes in a 2026 scoping review 14 | List them; they matter for surgery day, not for the implant itself |
Why the dentist needs your full medicine list
An implant depends on two things your body does. Blood has to clot after surgery, and bone has to grow onto the implant over the following months. Some medicines change one or the other.
The studies below find links in groups of people, not proof that a tablet causes a failure. A medicine can stand in for the illness it treats. That is one more reason never to stop a medicine because of a study.
The list also matters on surgery day itself. The clinic may give you painkillers or antibiotics, and some common painkillers add to bleeding in people on blood thinners. Allergies and every tablet you take, including ones bought without a prescription, belong on the form.
Bone-strengthening drugs and MRONJ
Bisphosphonates, such as alendronate, and denosumab are used to treat osteoporosis. They protect the spine and hips by slowing the cells that break bone down. That same effect can slow the normal repair of jawbone after surgery.
The rare complication is MRONJ, short for medication-related osteonecrosis of the jaw. An area of jawbone is exposed or dies and does not heal. It can be painful and slow to treat.
A 2025 review written for the International Task Force on Osteonecrosis of the Jaw pooled 21 cohorts 1. The rate of MRONJ after implants in people on these drugs was 0.5% 1. In one adjusted study, bisphosphonates added 3 cases of MRONJ per 1,000 patients 1.
0.5%pooled rate of MRONJ after implants in people on bone-strengthening drugs for osteoporosis, across 21 cohorts 1.
3 per 1,000extra MRONJ cases with bisphosphonates in the one adjusted study 1.
Implant failure is a separate question. The same review found no clear rise in failure per patient, with a relative risk of 0.82 and very low certainty 1. A second 2025 review of 21 studies also found no link per patient, but did find one per implant, with a risk ratio of 1.74 2. The two reviews point in opposite directions per implant, so treat that part as unsettled.
Denosumab has less research. The second review said it is unknown whether denosumab is linked to MRONJ around implants 2. A 2026 Korean study of 806 women aged 55 or older found implant survival of 99.13% with bisphosphonates, 98.08% with denosumab and 98.24% without these drugs 13. The differences were not significant 13.
Cancer doses are a different situation
High doses of the same drugs, given for cancer that has spread to bone, carry a high risk of complications after implant surgery 8. A scoping review of 28 studies found implants in these patients are widely discouraged 9. It advises that implants for high-dose or long-term low-dose patients be limited to centres set up for these cases 9.
Radiotherapy to the head or neck also lowers implant survival 8. If you have had cancer treatment with these drugs, or radiation to the jaw, tell us and the dentist before anything else is planned.
Breaks from the drug
Some dentists and doctors talk about pausing a bisphosphonate before surgery. This page found no study that settles whether a pause lowers the risk around implants, and the scoping review found the evidence too thin to link dose or duration to MRONJ 9. Only the doctor who prescribed it should decide, because stopping can weaken the protection for your spine and hips.
Blood thinners
Blood thinners come in three main kinds. Warfarin is a vitamin K antagonist. The newer tablets, such as apixaban and rivaroxaban, are called DOACs. Antiplatelet drugs, such as aspirin and clopidogrel, work in a different way again.
Stopping a blood thinner lowers bleeding risk but raises the risk of a clot, which can mean a stroke 3. That is why the decision is a balance, and why your own doctor has to be part of it.
- A 2021 review of 8 studies, with 1,467 people and at least 2,366 implants, found more bleeding with anticoagulants, a risk ratio of 2.30, but none of it clinically significant 3.
- Simple local measures at the chair, such as pressure, stitches and gauze with clotting agents, controlled it 3.
- A 2023 review of 7 studies found that continuing anticoagulants did not increase bleeding when local measures were used 4. Warfarin may bleed more than DOACs 4.
- A 2021 review of 5 prospective studies found the absolute risk low and saw no need to stop or change the dose for implant surgery 10.
Not every study agrees on DOACs. A 2025 French study followed 523 people on anticoagulants having oral, implant or gum surgery 12. Bleeding was more frequent in people who kept taking a DOAC than in people who kept taking warfarin, 15.9 against 5.9 events per 100 person-months 12. The authors suggest a short pause of the DOAC may help 12.
90.3%of bleeding events in the French study happened within 7 days of the procedure, and all were local bleeding 12.
So advice on pausing a DOAC differs between studies. Keep taking it unless your doctor and the dentist agree otherwise, in writing, before you travel.
Antidepressants, stomach-acid tablets and painkillers
These are common medicines, and the research on them is newer and weaker than on bone drugs or blood thinners.
- SSRIs, a common type of antidepressant, more than doubled the risk of implant failure in a review of 6 studies, with a pooled risk ratio of 2.44 11.
- In those studies, failure per patient ran at 5.6% to 19.6% in SSRI users against 1.9% to 8.0% in others 11.
- A separate review of 11 studies also found a risk ratio of 2.44, and limited evidence that sertraline may matter more than other SSRIs 5.
- For stomach-acid tablets, a review of 8 studies found an odds ratio of 2.71 in raw data, but 1.44 and not significant after adjusting for other factors 6.
- A 2026 scoping review of 51 studies linked long-term anti-inflammatory painkillers, prolonged acid tablets and SSRIs to more failure or bone loss 14.
None of this is a reason to stop an antidepressant or an acid tablet. Depression and reflux both need treating, and only the doctor who prescribed the medicine should change it. It is a reason to put them on the form, so the dentist can plan and watch healing more closely.
Medicines that did not change implant results
Some medicine groups looked neutral in the research. That is useful to know, because many people taking implants are older and on several tablets.
- Blood pressure tablets and immune-suppressing drugs had no effect on implant outcomes in a 2026 scoping review 14.
- People with heart and blood vessel disease had implant survival similar to or higher than healthy people in a 2018 review 8.
- In people aged 75 or older, implant survival was 97.3% at 1 year and 96.1% at 5 years 8.
They still go on the form. Blood pressure, for example, matters to how the surgery and any sedation are managed on the day.
What can go wrong, and how often
| Problem | How often | Source |
|---|---|---|
| MRONJ after implants, osteoporosis doses | 0.5% pooled across 21 cohorts 1 | Mirza 2025 1 |
| Bleeding on blood thinners | Risk ratio 2.30, none clinically significant 3 | Dawoud 2021 3 |
| Timing of bleeding on anticoagulants | 90.3% of events within 7 days 12 | Mahé 2025 12 |
| Implant failure with SSRIs, per patient | 5.6% to 19.6%, against 1.9% to 8.0% 11 | Shariff 2023 11 |
| Implant failure with denosumab for osteoporosis | Survival 98.08%, against 98.24% without these drugs 13 | Hwang 2026 13 |
Signs worth acting on are bleeding that does not stop with firm pressure on gauze, exposed bone in the mouth, or pain and swelling that get worse instead of better. Contact the clinic, and see a dentist or doctor at home if it cannot wait.
Where the evidence is weak
- Much of the evidence on bone-strengthening drugs is rated very low certainty by the reviewers themselves 1, 2.
- Whether denosumab raises MRONJ risk around implants is unknown 2.
- For antidepressants and acid tablets, all the studies are observational, and the tablet may be a marker for the condition it treats 11.
- Advice on pausing DOACs differs: one review sees no need, while a prospective French study suggests a short pause may help 10, 12.
- No study found looked at flying home soon after implant surgery while on a blood thinner.
Common beliefs that are not quite right
- Osteoporosis drugs rule out implants. At osteoporosis doses, implant survival was reported to be high, and MRONJ was rare 1, 8.
- Everyone stops blood thinners before dental surgery. Reviews found the extra bleeding minor and controlled at the chair, and stopping raises clot risk 3, 4.
- Stopping an antidepressant for a few weeks protects the implant. No study shows that, and the link may come from the illness rather than the tablet 11.
- Over-the-counter tablets do not count. Long-term anti-inflammatory painkillers were linked to more failure or bone loss 14.
- A cancer dose and an osteoporosis dose are the same risk. Cancer doses carry a high risk of complications after implant surgery 8.
What this means if you are flying to Vietnam for implants
Medicines are one of the things to sort out at home, before dates are set. A decision about a blood thinner or a bone drug needs your own doctor, and that is far easier in person at home than by email from Vietnam.
What to send before booking
- A full list of every medicine you take, with the dose and how often, including tablets bought without a prescription.
- For bone-strengthening drugs: the name, the dose, how it is given, when you started, and whether it is for osteoporosis or cancer.
- For blood thinners: the name, the reason you take it, and your latest INR result if you take warfarin.
- Any cancer treatment, including radiation to the head or neck.
- Allergies to any medicine, including antibiotics and painkillers.
- Recent X-rays, and a 3D scan if you already have one.
At the consultation in Vietnam, expect the dentist to ask the questions below.
- Which medicines do you take every day, and which only now and then?
- Have you ever had a bone-strengthening injection or tablet, even years ago?
- Do you bleed for a long time after a cut or a tooth removal?
- Has your doctor said anything about your medicines and dental surgery?
Then the timing. Talk to the doctor who prescribes each important medicine before you book, and bring any written advice with you. If your doctor agrees to pause a blood thinner, ask how that fits around the long flight and the days after surgery.
Implant treatment through us is two trips of about 7 days each, 3 to 6 months apart while the bone heals. In the French study, most bleeding came in the first week after the procedure 12. On a trip of about a week, much of that window falls while you are still close to the clinic.
Bring enough of every medicine for the whole trip and a few spare days, in your hand luggage, in the original packs, with a copy of your prescriptions. Keep the clinic's written instructions for the healing months at home, and tell your GP and dentist at home what was done.
Questions to ask the dentist
- Which of my medicines change your plan, and how?
- Do you need my doctor's view on any of them, in writing?
- Should I keep taking my blood thinner, and will you agree that with my doctor?
- Which painkillers and antibiotics will you give me, and are they safe with my medicines?
- Does my bone-strengthening drug change the number of implants or the kind of surgery?
- Who should I contact if bleeding or pain starts after I fly home?
What we at The Hudson decide, and what we do not
The Hudson plans and coordinates dental trips to Vietnam for people travelling from Australia, New Zealand and the UK. We are not a clinic.
We never tell you to start, stop or change a medicine. The treating dentist at the partner clinic decides how your medicines affect the implant plan, and your own doctor decides about the medicines themselves.
Our part is practical. We pass your medicine list, X-rays and notes to the clinic before you fly, so the plan is not being invented on the morning you arrive. If the dentist needs a letter from your doctor, we tell you early, so there is time to get it. You are welcome to ask us how a plan compares with what the research says.
The clinic pays us a referral fee for each patient. You pay us nothing. You are welcome to ask us how a plan compares with what the research says.
Quick answers
Should I stop my blood thinner before implant surgery?
Not on your own. Reviews found the extra bleeding is usually minor and controlled at the chair 3, 4. Your dentist and your doctor decide together, case by case.
Can I have implants if I take a bisphosphonate or denosumab for osteoporosis?
Often yes, with care. The rare risk is MRONJ, which one review put at 0.5% after implants 1. The dentist weighs it in your case.
What is MRONJ?
It stands for medication-related osteonecrosis of the jaw. An area of jawbone is exposed or dies and does not heal. It is rare at osteoporosis doses and more common at cancer doses 1, 8.
Should I stop my antidepressant before getting implants?
No, not because of the implant. SSRIs were linked to more failure, but the studies cannot show the tablet is the cause 11. Tell the dentist you take it, and leave any change to your doctor.
When is bleeding most likely after implant surgery on a blood thinner?
Mostly in the first week. In a French study of people on anticoagulants, 90.3% of bleeding events came within 7 days 12.
Read next
- Dental implants
- The complete implant survival guide
- Can I get dental implants if I have diabetes?
- Can I get dental implants if I smoke?
- Do I need to treat gum disease before getting dental implants?
- What happens if my dental work fails after I fly home?
- Is it safe to get dental work in Vietnam?
- Can I get dental implants and my new teeth in one trip, or do I need two?
Sources
- Mirza R, El Rabbany M, Ali DS, et al. Dental Implant Failure and Medication-Related Osteonecrosis of the Jaw Related to Dental Implants in Patients Taking Antiresorptive Therapy for Osteoporosis: A Systematic Review and Meta-Analysis. Endocrine practice, 2025. Systematic review and meta-analysis. PubMed 40505730. DOI 10.1016/j.eprac.2025.06.003.
- Lin L, Ren Y, Wang X, et al. Effects of Bisphosphonates and Denosumab on Dental Implants: A Systematic Review With Meta-Analysis. Oral diseases, 2025. Systematic review and meta-analysis. PubMed 40326505. DOI 10.1111/odi.15373.
- Dawoud BES, Kent S, Tabbenor O, et al. Dental implants and risk of bleeding in patients on oral anticoagulants: a systematic review and meta-analysis. International journal of implant dentistry, 2021. Systematic review and meta-analysis. PubMed 34430994. DOI 10.1186/s40729-021-00364-5.
- Zou L, Hua L. Risk of bleeding with dental implant surgery in patients on anticoagulant or antiplatelet drugs: a systematic review and meta-analysis. Acta odontologica Scandinavica, 2023. Systematic review and meta-analysis. PubMed 35763663. DOI 10.1080/00016357.2022.2085324.
- Harutyunyan L, Lieuw K, Yang B, et al. The Effect of Antidepressants on Dental Implant Failure: A Systematic Review and Meta-analysis. The International journal of oral & maxillofacial implants, 2024. Systematic review and meta-analysis. PubMed 38498803. DOI 10.11607/jomi.10798.
- Tang M, Xie Z. Does the use of proton pump inhibitors lead to an increased risk of dental implant failure? A systematic review and meta-analysis. Medicina oral, patologia oral y cirugia bucal, 2025. Systematic review and meta-analysis. PubMed 40421992. DOI 10.4317/medoral.27043.
- Chappuis V, Avila-Ortiz G, Araújo MG, et al. Medication-related dental implant failure: Systematic review and meta-analysis. Clinical oral implants research, 2018. Systematic review and meta-analysis. PubMed 30328197. DOI 10.1111/clr.13137.
- Schimmel M, Srinivasan M, McKenna G, et al. Effect of advanced age and/or systemic medical conditions on dental implant survival: A systematic review and meta-analysis. Clinical oral implants research, 2018. Systematic review and meta-analysis. PubMed 30328186. DOI 10.1111/clr.13288.
- Andersen SWM, Hindocha NV, Poulsen I, et al. Medication-Related Osteonecrosis of the Jaws in Patients on Antiresorptive Medication With Dental Implants. A Scoping Review. Clinical oral implants research, 2025. Scoping review. PubMed 40531168. DOI 10.1111/clr.14453.
- Miziara LNB, Sendyk WR, Ortega KL, et al. Risk of Bleeding during Implant Surgery in Patients Taking Antithrombotics: A Systematic Review. Seminars in thrombosis and hemostasis, 2021. Systematic review and meta-analysis. PubMed 33971681. DOI 10.1055/s-0041-1722845.
- Shariff JA, Gurpegui Abud D, Bhave MB, et al. Selective Serotonin Reuptake Inhibitors and Dental Implant Failure: A Systematic Review and Meta-Analysis. The Journal of oral implantology, 2023. Systematic review and meta-analysis. PubMed 37527173. DOI 10.1563/aaid-joi-d-22-00170.
- Mahé I, Hajage D, Monnet-Corti V, et al. Oral anticoagulant periprocedural management in patients undergoing an oral, dental implant or periodontal surgery: a prospective national observational survey. Research and practice in thrombosis and haemostasis, 2025. Prospective national observational study. PubMed 40492254. DOI 10.1016/j.rpth.2025.102848.
- Hwang J, Yoon Y, Byun G, et al. The Survival of Dental Implants in Post-Menopausal Women Receiving Denosumab: A Retrospective Cohort Study. Clinical implant dentistry and related research, 2026. Retrospective cohort study. PubMed 41562427. DOI 10.1111/cid.70122.
- Monje A, Soldini MC, Couso-Queiruga E, et al. Effect of Medication Intake on Dental Implant-Related Outcomes-A Scoping Review. Clinical oral implants research, 2026. Scoping review. PubMed 42402755. DOI 10.1111/clr.70151.
How we made this article: it is written from the studies listed above. Before it went live, every study was looked up, every quote matched to the study's abstract and every number checked against the study it comes from. Prices come only from our own price list. Hudson reads every article after it goes live, and the date it changed is shown at the top. This is general information, not advice for your own mouth: the dentist who examines you decides what is right for you. The Hudson plans and coordinates treatment at partner clinics in Hanoi; we are not a clinic. About the author.